Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 2, 2012, Pages 600-605

  Sen, Nandini ^a   Che, Xibing ^a   Rajamani, Jaya ^a   Zerboni, Leigh ^a   Sung, Phillip ^a   Ptacek, Jason ^a   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN INHIBITOR; S 3I 201; STAT3 PROTEIN; SURVIVIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; HERPES ZOSTER; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; INTRACELLULAR SIGNALING; LIFE CYCLE; MALE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; VARICELLA ZOSTER VIRUS; VIRION; VIRUS CARCINOGENESIS; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION; XENOGRAFT;

AMINOSALICYLIC ACIDS; ANIMALS; BENZENESULFONATES; FLOW CYTOMETRY; HERPESVIRUS 3, HUMAN; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LUMINESCENT MEASUREMENTS; MICE; MICE, SCID; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; VIRUS REPLICATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 3; MUS;

EID: 84856015015     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1114232109     Document Type: Article

References (40)

1. Cohen JI, Straus SE, Arvin AM (2007) Varicella-zoster virus replication, pathogenesis, and management. Fields Virology, eds Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Strause SE. (Lippincott Williams & Wilkins, Philadelphia, PA), 5th Ed, Vol 2, pp 2773-2818.
2. Arvin AM, et al. (2010) Varicella-zoster virus T cell tropism and the pathogenesis of skin infection. Curr Top Microbiol Immunol 342:189-209.
3. Zerboni L, Ku CC, Jones CD, Zehnder JL, Arvin AM (2005) Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci USA 102:6490-6495. (Pubitemid 40617470)
4. Sen N, et al. (2010) Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: A novel mechanism of IRF3 inhibition among herpesviruses. J Virol 84:9240-9253.
5. Jones JO, Arvin AM (2006) Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J Virol 80:5113-5124.
6. Ku CC, et al. (2004) Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med 200:917-925.
7. Darnell JE, Jr. (1997) STATs and gene regulation. Science 277:1630-1635.
8. Levy DE, Darnell JE, Jr. (2002) Stats: Transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651-662. (Pubitemid 34987786)
9. Jarnicki A, Putoczki T, Ernst M (2010) Stat3: Linking inflammation to epithelial cancer-More than a "gut" feeling? Cell Div 5:14.
10. Akira S (1999) Functional roles of STAT family proteins: Lessons from knockout mice. Stem Cells 17(13):138-146.
11. Al Zaid Siddiquee K, Turkson J (2008) STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res 18:254-267. (Pubitemid 351206162)
12. Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: A leading role for STAT3. Nat Rev Cancer 9:798-809.
13. Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell JE, Jr. (1998) Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol 18:2553-2558. (Pubitemid 28183425)
14. Punjabi AS, Carroll PA, Chen L, Lagunoff M (2007) Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. J Virol 81:2449-2458.
15. Wang Z, et al. (2010) STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 and ERK signaling. Eur J Cancer 46:2996-3006.
16. Chung YH, et al. (2004) Activation of Stat3 transcription factor by Herpesvirus saimiri STP-A oncoprotein. J Virol 78:6489-6497.
17. O'Connor DS, et al. (2000) Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 97:13103-13107.
18. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921. (Pubitemid 27353455)
19. Aoki Y, Feldman GM, Tosato G (2003) Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 101: 1535-1542. (Pubitemid 36182531)
20. Gu L, Chiang KY, Zhu N, Findley HW, Zhou M (2007) Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines. Exp Hematol 35:957-966. (Pubitemid 46813191)
21. Siddiquee K, et al. (2007) Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci USA 104:7391-7396. (Pubitemid 47185916)
22. Jones JO, Sommer M, Stamatis S, Arvin AM (2006) Mutational analysis of the varicellazoster virus ORF62/63 intergenic region. J Virol 80:3116-3121. (Pubitemid 43346411)
23. Moffat JF, Stein MD, Kaneshima H, Arvin AM (1995) Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J Virol 69:5236-5242.
24. Reichelt M, Brady J, Arvin AM (2009) The replication cycle of varicella-zoster virus: Analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. J Virol 83:3904-3918.
25. Nakahara T, et al. (2007) YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res 67:8014-8021. (Pubitemid 47395135)
26. Kung CP, Meckes DG, Jr., Raab-Traub N (2011) Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta. J Virol 85:4399-4408.
27. Faqing T, et al. (2005) Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma. Exp Oncol 27(2):96-101. (Pubitemid 41025729)
28. Lu J, et al. (2009) Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-associated B-lymphoma cells and contributes to their proliferation. J Virol 83:7129-7141.
29. Lin L, et al. (2009) The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene 28:961-972.
30. Regis G, Pensa S, Boselli D, Novelli F, Poli V (2008) Ups and downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. Semin Cell Dev Biol 19:351-359.
31. Gritsko T, et al. (2006) Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 12(1):11-19. (Pubitemid 43166170)
32. Connell CM, Wheatley SP, McNeish IA (2008) Nuclear survivin abrogates multiple cell cycle checkpoints and enhances viral oncolysis. Cancer Res 68:7923-7931.
33. Moffat JF, Greenblatt RJ (2010) Effects of varicella-zoster virus on cell cycle regulatory pathways. Curr Top Microbiol Immunol 342:67-77.
34. Botto S, et al. (2011) IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin. Blood 117: 352-361.
35. Slinger E, et al. (2010) HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal 3:ra58.
36. Wang L, et al. (2011) Disruption of PML nuclear bodies is mediated by ORF61 SUMOinteracting motifs and required for varicella-zoster virus pathogenesis in skin. PLoS Pathog 7:e1002157.
37. Botchkareva NV, Kahn M, Ahluwalia G, Shander D (2007) Survivin in the human hair follicle. J Invest Dermatol 127:479-482.
38. Docherty JJ, Sweet TJ, Bailey E, Faith SA, Booth T (2006) Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Res 72(3):171-177. (Pubitemid 44708309)
39. Yu LJ, et al. (2008) Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Neoplasia 10:736-744.
40. Zhang X, Zhang J, Wang L, Wei H, Tian Z (2007) Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. BMC Cancer 7:149.